Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0D4OS
|
|||
Former ID |
DNCL001727
|
|||
Drug Name |
VM-202
|
|||
Indication | Angina pectoris [ICD-11: BA40] | Phase 3 | [1] | |
Diabetic foot ulcer [ICD-11: BD54] | Phase 3 | [2] | ||
Peripheral arterial disease [ICD-11: BD4Z; ICD-10: I73, I73.9] | Phase 3 | [3] | ||
Peripheral neuropathy [ICD-11: 8C0Z] | Phase 3 | [4] | ||
Amyotrophic lateral sclerosis [ICD-11: 8B60.0; ICD-9: 335.2] | Phase 2 | [5] | ||
Company |
ViroMed
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02427464) Phase 3 Gene Therapy for Painful Diabetic Neuropathy. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 5 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 6 | Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model. Eur J Cardiothorac Surg. 2008 Oct;34(4):857-63. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.